Is Ocular Therapeutix (NASDAQ:OCUL) Weighed On By Its Debt Load?

Simply Wall StJan 10 03:52

Ocular Therapeutix to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation

GlobeNewswireJan 8 20:00

EyePoint Initiated at Buy by Citi on WAMD Drug Potential

Seeking AlphaJan 8 02:37

BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $18

Futu NewsJan 7 08:31 · Ratings

Ocular Therapeutix (OCUL) Receives a Buy From Bank of America Securities

TipRanksJan 7 08:20 · Ratings

Investors Might Be Losing Patience for Ocular Therapeutix's (NASDAQ:OCUL) Increasing Losses, as Stock Sheds 12% Over the Past Week

Yahoo FinanceDec 19, 2024 22:31